Theriva biologics to participate in the b. riley securities 3rd annual oncology conference

Rockville, md., jan. 17, 2023 (globe newswire) -- theriva biologics (nyse american: tovx), (“theriva” or the “company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that company's management will provide a corporate update and participate in one-on-one investor meetings at the the b. riley securities 3rd annual oncology conference, to be held virtually from january 18-19, 2023.
TOVX Ratings Summary
TOVX Quant Ranking